Last reviewed · How we verify

Blood sampling for pharmacokinetics

Erasmus Medical Center · Phase 2 active Small molecule

Blood sampling for pharmacokinetics is a clinical procedure to measure drug concentrations in blood over time to assess absorption, distribution, and elimination.

At a glance

Generic nameBlood sampling for pharmacokinetics
SponsorErasmus Medical Center
ModalitySmall molecule
PhasePhase 2

Mechanism of action

This is not a drug itself, but rather a diagnostic procedure used during clinical trials to characterize how a drug is processed by the body. Pharmacokinetic sampling involves collecting blood samples at predetermined timepoints to measure plasma or serum drug concentrations, which are then analyzed to determine key parameters such as bioavailability, half-life, clearance, and volume of distribution.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: